SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-23-003994
Filing Date
2023-02-28
Accepted
2023-02-28 20:33:07
Documents
2
Period of Report
2023-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1760
2 poa_shaw.htm EX-24 7361
  Complete submission text file 0001567619-23-003994.txt   10465
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9000 VIRGINIA MANOR ROAD SUITE 200 BELTSVILLE MD 20705
Business Address
Shaw Kevin G. (Reporting) CIK: 0001953666 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 23689047